Your browser doesn't support javascript.
loading
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells.
Qiu, Xiaofu; Wang, Wei; Li, Bijun; Cheng, Bo; Lin, Kangjian; Bai, Jian; Li, Huanhui; Yang, Guosheng.
Afiliación
  • Qiu X; Department of Urology, Southern Medical University Third Medical College, Guangzhou, 510317, China. xfqiu123@163.com.
  • Wang W; Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, 510317, China. xfqiu123@163.com.
  • Li B; Department of Urology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, 510515, China.
  • Cheng B; Department of Urology, the Second Affiliated Hospital of Guangdong Medical College, Zhanjiang, 524003, China.
  • Lin K; Department of Urology, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Bai J; Department of Urology, Southern Medical University Third Medical College, Guangzhou, 510317, China.
  • Li H; Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, 510317, China.
  • Yang G; Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, 510317, China.
BMC Cancer ; 19(1): 27, 2019 Jan 08.
Article en En | MEDLINE | ID: mdl-30621625
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / MicroARNs / Proteína Potenciadora del Homólogo Zeste 2 Límite: Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / MicroARNs / Proteína Potenciadora del Homólogo Zeste 2 Límite: Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: China